Healthcare reimbursement refers to the payment received by healthcare providers like physicians, hospitals and others from either patients or insurance companies. Reimbursements enable access to quality care for the patients by compensating the costs incurred during treatment. Factors such as rising geriatric population, rising chronic diseases, increasing health insurance penetration and emergence of new regulatory reforms can drive the market growth during the forecast period. However, unclear reimbursement policies and reduced funding in the public sector can hamper the market growth.
Market Dynamics:
Global healthcare reimbursement market growth is driven by factors such as increasing prevalence of chronic diseases, growing geriatric population, rising healthcare costs, expansion of private health insurance across developing nations and introduction of favorable reimbursement frameworks by governments promoting universal healthcare. According to estimates, chronic diseases affected 133 million Americans in 2016 and contributed to US$ 3.7 trillion in annual healthcare costs. Such high costs have led to the development of favorable reimbursement policies that aim to increase access to care. However, reimbursement landscape present challenges in terms of unclear policies and processes, thus, resulting in declining reimbursement rates in some countries. Lack of funding and budgetary constraints in the public sector can also hamper the market growth. Meanwhile, digitization of reimbursement processes and entry of new players in the market can offer opportunities for market growth during the forecast period.
Key features of the study
- -This report provides in-depth analysis of the global healthcare reimbursement market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global healthcare reimbursement market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include UnitedHealth Group, Aviva, Allianz, CVS Health, BNP Paribas, Aetna, Nippon Life Insurance, WellCare Health Plans, AgileHealthInsurance and Blue Cross Blue Shield Association
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global healthcare reimbursement market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare reimbursement market.
Detailed Segmentation-
- By Claim
- By Payer
- Private Payers
- Public Payers
- By Service Provider
- Physician office
- Hospitals & Clinics
- Diagnostic Laboratories
- Medical Equipment & Supplies
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- UnitedHealth Group
- Aviva
- Allianz
- CVS Health Corporation
- Bupa
- Aon plc
- Cigna Corporation
- Centene Corporation
- Anthem, Inc.
- Blue Cross Blue Shield Association (BCBSA)
- Humana Inc.
- WellCare Health Plans, Inc.
- Medicaid Services (CMS)
- Health Care Service Corporation (HCSC)
- Anthem Blue Cross Blue Shield
- Molina Healthcare, Inc.
- Kaiser Permanente